drugset / Trial / NCT05041699
PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel
Phase 1
Completed
40 enrolled
International Partnership for Microbicides, Inc.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collabNational Institutes of Health (NIH) · collab
RandomizedParallel-groupQuadruple-blindDiagnostic
Summary
A double-blind, randomized trial (1:1) to characterize the local and systemic pharmacokinetics (PK) of two DPV-LNG vaginal ring formulations
Timeline
- Start
- 2022-06-20
- Primary completion
- 2024-10-07
- Completion
- 2024-10-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levonorgestrel | Small molecule | — | Other |
| Subject | dapivirine | Small molecule | — | Other |